 | • レポートコード：QYR2104Z2614 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、痛風治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（急性痛風、慢性痛風）、用途別市場規模（病院、診療所、在宅ケア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・痛風治療の市場動向 ・企業の競争状況、市場シェア ・痛風治療の種類別市場規模（急性痛風、慢性痛風） ・痛風治療の用途別市場規模（病院、診療所、在宅ケア、その他） ・痛風治療の北米市場規模2016-2027（アメリカ、カナダ） ・痛風治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・痛風治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・痛風治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・痛風治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Takeda Pharmaceutical、Novartis、Savient Pharmaceuticals、AstraZeneca、GlaxoSmithKline、Merck& Co、Teijin Pharma、Regeneron Pharmaceuticals、Polaris、BioCryst Pharmaceuticals、Nippon Chemiphar、JW Pharmaceutical） ・結論 |
Gout is a disease characterized by recurrent attacks of acute inflammatory arthritis.
The increase in the number of gout disease incidences and strong development of the treatment are some of the major factors driving the global gout disease treatment market. Improvised study on gout therapeutics and introduction of niche drugs are other factors boosting the growth of the global gout disease treatment market.
Market Analysis and Insights: Global Gout Disease Treatment Market
The global Gout Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gout Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gout Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gout Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gout Disease Treatment market.
Global Gout Disease Treatment Scope and Market Size
Gout Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gout Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Acute Gout
Chronic Gout
Segment by Application
Hospitals
Clinics
Homecare Settings
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Takeda Pharmaceutical
Novartis
Savient Pharmaceuticals
AstraZeneca
GlaxoSmithKline
Merck& Co
Teijin Pharma
Regeneron Pharmaceuticals
Polaris
AstraZeneca
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gout Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acute Gout
1.2.3 Chronic Gout
1.3 Market by Application
1.3.1 Global Gout Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare Settings
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gout Disease Treatment Market Perspective (2016-2027)
2.2 Gout Disease Treatment Growth Trends by Regions
2.2.1 Gout Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gout Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Gout Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Gout Disease Treatment Industry Dynamic
2.3.1 Gout Disease Treatment Market Trends
2.3.2 Gout Disease Treatment Market Drivers
2.3.3 Gout Disease Treatment Market Challenges
2.3.4 Gout Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gout Disease Treatment Players by Revenue
3.1.1 Global Top Gout Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Gout Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Gout Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gout Disease Treatment Revenue
3.4 Global Gout Disease Treatment Market Concentration Ratio
3.4.1 Global Gout Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gout Disease Treatment Revenue in 2020
3.5 Gout Disease Treatment Key Players Head office and Area Served
3.6 Key Players Gout Disease Treatment Product Solution and Service
3.7 Date of Enter into Gout Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gout Disease Treatment Breakdown Data by Type
4.1 Global Gout Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Gout Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Gout Disease Treatment Breakdown Data by Application
5.1 Global Gout Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Gout Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Gout Disease Treatment Market Size (2016-2027)
6.2 North America Gout Disease Treatment Market Size by Type
6.2.1 North America Gout Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Gout Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Gout Disease Treatment Market Size by Type (2016-2027)
6.3 North America Gout Disease Treatment Market Size by Application
6.3.1 North America Gout Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Gout Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Gout Disease Treatment Market Size by Application (2016-2027)
6.4 North America Gout Disease Treatment Market Size by Country
6.4.1 North America Gout Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Gout Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Gout Disease Treatment Market Size (2016-2027)
7.2 Europe Gout Disease Treatment Market Size by Type
7.2.1 Europe Gout Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Gout Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Gout Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Gout Disease Treatment Market Size by Application
7.3.1 Europe Gout Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Gout Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Gout Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Gout Disease Treatment Market Size by Country
7.4.1 Europe Gout Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Gout Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Gout Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Gout Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Gout Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gout Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gout Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Gout Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Gout Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gout Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gout Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Gout Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Gout Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gout Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gout Disease Treatment Market Size (2016-2027)
9.2 Latin America Gout Disease Treatment Market Size by Type
9.2.1 Latin America Gout Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Gout Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Gout Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Gout Disease Treatment Market Size by Application
9.3.1 Latin America Gout Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Gout Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Gout Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Gout Disease Treatment Market Size by Country
9.4.1 Latin America Gout Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Gout Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gout Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Gout Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Gout Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gout Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gout Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Gout Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Gout Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gout Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gout Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Gout Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Gout Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gout Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Details
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Gout Disease Treatment Introduction
11.1.4 Takeda Pharmaceutical Revenue in Gout Disease Treatment Business (2016-2021)
11.1.5 Takeda Pharmaceutical Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gout Disease Treatment Introduction
11.2.4 Novartis Revenue in Gout Disease Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Savient Pharmaceuticals
11.3.1 Savient Pharmaceuticals Company Details
11.3.2 Savient Pharmaceuticals Business Overview
11.3.3 Savient Pharmaceuticals Gout Disease Treatment Introduction
11.3.4 Savient Pharmaceuticals Revenue in Gout Disease Treatment Business (2016-2021)
11.3.5 Savient Pharmaceuticals Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Gout Disease Treatment Introduction
11.4.4 AstraZeneca Revenue in Gout Disease Treatment Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Gout Disease Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Gout Disease Treatment Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck& Co
11.6.1 Merck& Co Company Details
11.6.2 Merck& Co Business Overview
11.6.3 Merck& Co Gout Disease Treatment Introduction
11.6.4 Merck& Co Revenue in Gout Disease Treatment Business (2016-2021)
11.6.5 Merck& Co Recent Development
11.7 Teijin Pharma
11.7.1 Teijin Pharma Company Details
11.7.2 Teijin Pharma Business Overview
11.7.3 Teijin Pharma Gout Disease Treatment Introduction
11.7.4 Teijin Pharma Revenue in Gout Disease Treatment Business (2016-2021)
11.7.5 Teijin Pharma Recent Development
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Details
11.8.2 Regeneron Pharmaceuticals Business Overview
11.8.3 Regeneron Pharmaceuticals Gout Disease Treatment Introduction
11.8.4 Regeneron Pharmaceuticals Revenue in Gout Disease Treatment Business (2016-2021)
11.8.5 Regeneron Pharmaceuticals Recent Development
11.9 Polaris
11.9.1 Polaris Company Details
11.9.2 Polaris Business Overview
11.9.3 Polaris Gout Disease Treatment Introduction
11.9.4 Polaris Revenue in Gout Disease Treatment Business (2016-2021)
11.9.5 Polaris Recent Development
11.10 BioCryst Pharmaceuticals
11.10.1 BioCryst Pharmaceuticals Company Details
11.10.2 BioCryst Pharmaceuticals Business Overview
11.10.3 BioCryst Pharmaceuticals Gout Disease Treatment Introduction
11.10.4 BioCryst Pharmaceuticals Revenue in Gout Disease Treatment Business (2016-2021)
11.10.5 BioCryst Pharmaceuticals Recent Development
11.11 Nippon Chemiphar
11.11.1 Nippon Chemiphar Company Details
11.11.2 Nippon Chemiphar Business Overview
11.11.3 Nippon Chemiphar Gout Disease Treatment Introduction
11.11.4 Nippon Chemiphar Revenue in Gout Disease Treatment Business (2016-2021)
11.11.5 Nippon Chemiphar Recent Development
11.12 JW Pharmaceutical
11.12.1 JW Pharmaceutical Company Details
11.12.2 JW Pharmaceutical Business Overview
11.12.3 JW Pharmaceutical Gout Disease Treatment Introduction
11.12.4 JW Pharmaceutical Revenue in Gout Disease Treatment Business (2016-2021)
11.12.5 JW Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Gout Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acute Gout
Table 3. Key Players of Chronic Gout
Table 4. Global Gout Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Gout Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gout Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Gout Disease Treatment Market Share by Regions (2016-2021)
Table 8. Global Gout Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Gout Disease Treatment Market Share by Regions (2022-2027)
Table 10. Gout Disease Treatment Market Trends
Table 11. Gout Disease Treatment Market Drivers
Table 12. Gout Disease Treatment Market Challenges
Table 13. Gout Disease Treatment Market Restraints
Table 14. Global Gout Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Gout Disease Treatment Market Share by Players (2016-2021)
Table 16. Global Top Gout Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gout Disease Treatment as of 2020)
Table 17. Ranking of Global Top Gout Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Gout Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gout Disease Treatment Product Solution and Service
Table 21. Date of Enter into Gout Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gout Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Gout Disease Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Gout Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Gout Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Gout Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Gout Disease Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Gout Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Gout Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Gout Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Gout Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Gout Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Gout Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Gout Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Gout Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Gout Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Gout Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Gout Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Gout Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Gout Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Gout Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Gout Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Gout Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gout Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gout Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gout Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Gout Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Gout Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Gout Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Gout Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Gout Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Gout Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Gout Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Gout Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Gout Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gout Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gout Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gout Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Gout Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Takeda Pharmaceutical Company Details
Table 62. Takeda Pharmaceutical Business Overview
Table 63. Takeda Pharmaceutical Gout Disease Treatment Product
Table 64. Takeda Pharmaceutical Revenue in Gout Disease Treatment Business (2016-2021) & (US$ Million)
Table 65. Takeda Pharmaceutical Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Gout Disease Treatment Product
Table 69. Novartis Revenue in Gout Disease Treatment Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Savient Pharmaceuticals Company Details
Table 72. Savient Pharmaceuticals Business Overview
Table 73. Savient Pharmaceuticals Gout Disease Treatment Product
Table 74. Savient Pharmaceuticals Revenue in Gout Disease Treatment Business (2016-2021) & (US$ Million)
Table 75. Savient Pharmaceuticals Recent Development
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Gout Disease Treatment Product
Table 79. AstraZeneca Revenue in Gout Disease Treatment Business (2016-2021) & (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Gout Disease Treatment Product
Table 84. GlaxoSmithKline Revenue in Gout Disease Treatment Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Merck& Co Company Details
Table 87. Merck& Co Business Overview
Table 88. Merck& Co Gout Disease Treatment Product
Table 89. Merck& Co Revenue in Gout Disease Treatment Business (2016-2021) & (US$ Million)
Table 90. Merck& Co Recent Development
Table 91. Teijin Pharma Company Details
Table 92. Teijin Pharma Business Overview
Table 93. Teijin Pharma Gout Disease Treatment Product
Table 94. Teijin Pharma Revenue in Gout Disease Treatment Business (2016-2021) & (US$ Million)
Table 95. Teijin Pharma Recent Development
Table 96. Regeneron Pharmaceuticals Company Details
Table 97. Regeneron Pharmaceuticals Business Overview
Table 98. Regeneron Pharmaceuticals Revenue in Gout Disease Treatment Business (2016-2021) & (US$ Million)
Table 99. Regeneron Pharmaceuticals Recent Development
Table 100. Polaris Company Details
Table 101. Polaris Business Overview
Table 102. Polaris Gout Disease Treatment Product
Table 103. Polaris Revenue in Gout Disease Treatment Business (2016-2021) & (US$ Million)
Table 104. Polaris Recent Development
Table 105. BioCryst Pharmaceuticals Company Details
Table 106. BioCryst Pharmaceuticals Business Overview
Table 107. BioCryst Pharmaceuticals Gout Disease Treatment Product
Table 108. BioCryst Pharmaceuticals Revenue in Gout Disease Treatment Business (2016-2021) & (US$ Million)
Table 109. BioCryst Pharmaceuticals Recent Development
Table 110. Nippon Chemiphar Company Details
Table 111. Nippon Chemiphar Business Overview
Table 112. Nippon Chemiphar Gout Disease Treatment Product
Table 113. Nippon Chemiphar Revenue in Gout Disease Treatment Business (2016-2021) & (US$ Million)
Table 114. Nippon Chemiphar Recent Development
Table 115. JW Pharmaceutical Company Details
Table 116. JW Pharmaceutical Business Overview
Table 117. JW Pharmaceutical Gout Disease Treatment Product
Table 118. JW Pharmaceutical Revenue in Gout Disease Treatment Business (2016-2021) & (US$ Million)
Table 119. JW Pharmaceutical Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gout Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Acute Gout Features
Figure 3. Chronic Gout Features
Figure 4. Global Gout Disease Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Homecare Settings Case Studies
Figure 8. Others Case Studies
Figure 9. Gout Disease Treatment Report Years Considered
Figure 10. Global Gout Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Gout Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gout Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Gout Disease Treatment Market Share by Regions (2022-2027)
Figure 14. Global Gout Disease Treatment Market Share by Players in 2020
Figure 15. Global Top Gout Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gout Disease Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Gout Disease Treatment Revenue in 2020
Figure 17. Global Gout Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Gout Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Gout Disease Treatment Market Share by Type (2016-2027)
Figure 21. North America Gout Disease Treatment Market Share by Application (2016-2027)
Figure 22. North America Gout Disease Treatment Market Share by Country (2016-2027)
Figure 23. United States Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gout Disease Treatment Market Share by Type (2016-2027)
Figure 27. Europe Gout Disease Treatment Market Share by Application (2016-2027)
Figure 28. Europe Gout Disease Treatment Market Share by Country (2016-2027)
Figure 29. Germany Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gout Disease Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Gout Disease Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Gout Disease Treatment Market Share by Region (2016-2027)
Figure 39. China Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gout Disease Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Gout Disease Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Gout Disease Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gout Disease Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Gout Disease Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Gout Disease Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Gout Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Takeda Pharmaceutical Revenue Growth Rate in Gout Disease Treatment Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Gout Disease Treatment Business (2016-2021)
Figure 60. Savient Pharmaceuticals Revenue Growth Rate in Gout Disease Treatment Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Gout Disease Treatment Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Gout Disease Treatment Business (2016-2021)
Figure 63. Merck& Co Revenue Growth Rate in Gout Disease Treatment Business (2016-2021)
Figure 64. Teijin Pharma Revenue Growth Rate in Gout Disease Treatment Business (2016-2021)
Figure 65. Regeneron Pharmaceuticals Revenue Growth Rate in Gout Disease Treatment Business (2016-2021)
Figure 66. Polaris Revenue Growth Rate in Gout Disease Treatment Business (2016-2021)
Figure 67. BioCryst Pharmaceuticals Revenue Growth Rate in Gout Disease Treatment Business (2016-2021)
Figure 68. Nippon Chemiphar Revenue Growth Rate in Gout Disease Treatment Business (2016-2021)
Figure 69. JW Pharmaceutical Revenue Growth Rate in Gout Disease Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の痛風治療市場規模・現状・予測（2021年-2027年） Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to …- 世界の痛風治療市場規模・現状・予測（2021年-2027年） Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to …
- 世界のクラッベ病治療市場規模・現状・予測（2021年-2027年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- 世界の髄膜炎菌性疾患治療市場規模・現状・予測（2021年-2027年） Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant …
- 世界のニューカッスル病治療市場規模・現状・予測（2021年-2027年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…